If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause you a ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

As the year draws to a close, Wall Street is set to crown Eli Lilly (NYSE:LLY) among the best in Big Pharma, while Novo ...

The danger and hardship gets worse by the day for civilians in eastern Ukraine. Still, they resist leaving the places that have become their homes. By Tyler Hicks and Gaëlle Girbes Human rights ...

2024’s progress hints at things to come. Clark took the WNBA—and basketball—to a new level Banga is tasked with helping find funds for emissions reduction and climate change adaptation ...

Airports are warning of delays for both departing and arriving flights as thick fog continues around the country. Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus ...